Significance of lung resistance-related protein in the clinical outcome of acute leukaemic patients with reference to P-glycoprotein

British Journal of Haematology

Volumn 110, Issue 2, 2000, Pages 370-378

  Tsuji, Kazue ^a   Motoji, Toshiko ^b   Sugawara, Isamu ^c   Shiozaki, Hiroko ^d   Wang, Yan Hua ^b   Motomura, Sayuri ^b   Okada, Michiko ^e   Yasunami, Takeshi ^b   Sano, Fumiaki ^a   Takahashi, Masatomo ^a   Kawada, Hiroshi ^f   Maseki, Nobuo ^g   Hoshino, Shigeru ^h   Ishida, Masashi ^a   Mizoguchi, Hideaki ^b  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c Research Institute of Tuberculosis   (Japan)

^d SAISEIKAI MAEBASHI HOSPITAL   (Japan)

^e Department of Neurosurgery   (Japan)

^f TOKAI UNIVERSITY   (Japan)

^g Saitama Cancer Centre   (Japan)

^h SAITAMA RED CROSS HOSPITAL   (Japan)

Author keywords

Acute leukaemia; Lung resistance related protein; P glycoprotein

Indexed keywords

GLYCOPROTEIN P; LUNG RESISTANCE PROTEIN;

ACUTE LEUKEMIA; ADULT; ARTICLE; BLAST CELL; CANCER SURVIVAL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; HUMANS; LEUKEMIA; MIDDLE AGED; P-GLYCOPROTEINS; PROGNOSIS; TREATMENT OUTCOME;

EID: 0033836193     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02181.x     Document Type: Article

References (28)

1. Methods to detect p-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations
2. Proposals for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group
3. Overexpression of lung-resistance protein and increased p-glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival
4. Clinical significance of multidrug resistance P-glycoprotein expression on acute non-lymphoblastic leukemia cells at diagnosis
5. Clinical relevance of P-glycoprotein expression in de novo acute leukemia
6. Acute myeloid leukemia cells with low P-glycoprotein expression and high rhodamine 123 efflux capacity display high clonogenicity
7. Expression of the lung resistance protein predicts poor outcome in de novo acute myeloid leukemia
8. Multidrug resistance gene expression in acute myeloid leukemia: Major prognosis significance for in vivo drug resistance to induction treatment
9. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia
10. Randomized trials between behenoyl cytarabine and cytarabine in combiantion induction and consolidation therapy, and with or without ubenimex after maintenace/intensification therapy in adult myeloid leukemia
11. Acute myeloid leukemia in the elderly: Assesment of multidrug resistance (MDRI) and cytogenetics distinguished biologic subgroups with remarkably distinct response to standard chemotherapy. A southwest oncology group study
12. Frequency and clinical significance of the expression of the multidrug resistance proteins MDRI/P-glycoprotein, MRPI, and LRP in acute myeloid leukemia
13. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia
14. Over-expression of multidrug resistance-associated pl70-glycoprotein in acute non-lymphocytic leukemia
15. P-glycoprotein, lung resistance-related protein and multidug resistance associated protein in de novo acute non-lymphocytic leukaemias: Biological and clinical implications
16. No beneficial effect from addition of etoposide to daunorubicin, cytarabin, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: The JALSG-AML92 study
17. Modified histogram subtraction technique for analysis of flow cytometry data
18. Failure of remission induction in acute myelocytic leukemia
19. The drug resistance-related protein LRP is the human major vault protein
20. Overexpression of a Mr 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance
21. Increased drug permeability in chinese hamster ovary cells in the presence of cyanide
22. Lymphoblastic lymphoma in adults
23. Preferential expression of the multidrug-resistance-associated protein (MRP) in adenocarcinoma of the lung
24. Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDRI and MRP
25. The human multi-drug resistance (MDRI) gene: Cdna cloning and transcripton inhibition
26. Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: A pilot study
27. Recovery of drug resistance-reversing agent on acute myelogenous leukemic blasts and K562 cells resistant to adriamycin cell line